In this work, we studied for the first time the potential impact of novel FKBP12 ligands in DM1, studying the activity of MP compounds in human primary fibroblasts of DM1 patients and a Drosophila model of DM1 disease. This evidence concerns the gene FKBP1A and myotonic dystrophy type 1.